Long-Term Genomic Surveillance and Immune Escape of SARS-CoV-2 in the Republic of Korea, with a Focus on JN.1-Derived Variants
Viruses · 2025
DOI: 10.3390/v17091202 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Il-Hwan Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju 2815…. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Immune Evasion. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
Since the onset of the COVID-19 pandemic, the Republic of Korea has experienced continuous waves of SARS-CoV-2 variants. The current study aimed to analyze the long-term trends of variant prevalence and associated changes in immune responses within the country. Whole-genome sequencing was performed on confirmed patient samples collected from December 2020 to May 2025, and variant distribution, genetic diversity, and neutralization were compared. As a result of analyzing a total of 157,962 gene sequences, various Omicron sub-lineages, including BA.1, BA.2, BA.5, followed by JN.1, KP.3, and NB.1.8.1, were seen to circulate sequentially over time. The nucleotide diversity of the SARS-CoV-2 genome gradually increased after the JN.1 outbreak. Of the tested variants, hamster antiserum neutralization analysis indicated that Omicron NB.1.8.1, which began to circulate in 2025, exhibited the lowest neutralization activity, with an approximately 6.6-fold decrease compared to JN.1. This suggests a potential expansion in the dominance of new variants with enhanced immune evasion. As the transmission of SARS-CoV-2 continues, new variants with novel characteristics may emerge; therefore, continuous national genomic surveillance and immunological characterization are considered crucial for early detection of emerging variants and for guiding effective public health responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Emerging Infectious Diseases, Department of Laboratory Diagnosis and Analysis, Korea Disease Control and Prevention Agency, Cheongju 28159, Republic of Korea.
ORCID-Profile: Il-Hwan Kim, Eun Ju Lee, Jin Sun No, Ji Yeong Noh, Chae Young Lee, Sang Won O, Yong Jun Choi, Jeong-Ah Kim, Jeong-Hyun Nam, Jeong-Min Kim, Jee Eun Rhee, Eun-Jin Kim
Förderung
- Korea Disease Control and Prevention Agency
Zitieren
APA
Kim, I. H., Lee, E. J., No, J. S., Noh, J. Y., Lee, C. Y., O, S. W., Choi, Y. J., Kim, J. A., An, B. M., Nam, J. H., Kim, J. M., Rhee, J. E., & Kim, E. J. (2025). Long-Term Genomic Surveillance and Immune Escape of SARS-CoV-2 in the Republic of Korea, with a Focus on JN.1-Derived Variants. Viruses. https://doi.org/10.3390/v17091202
Vancouver
Kim IH, Lee EJ, No JS, Noh JY, Lee CY, O SW, et al. Long-Term Genomic Surveillance and Immune Escape of SARS-CoV-2 in the Republic of Korea, with a Focus on JN.1-Derived Variants. Viruses. 2025. doi:10.3390/v17091202
BibTeX
@article{Kim2025,
author = {Kim, Il-Hwan and Lee, Eun Ju and No, Jin Sun and Noh, Ji Yeong and Lee, Chae Young and O, Sang Won and Choi, Yong Jun and Kim, Jeong-Ah and An, Bo Min and Nam, Jeong-Hyun and Kim, Jeong-Min and Rhee, Jee Eun and Kim, Eun-Jin},
title = {Long-Term Genomic Surveillance and Immune Escape of SARS-CoV-2 in the Republic of Korea, with a Focus on JN.1-Derived Variants},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17091202}
}
EUVIMED